Chemical activators of Olr772 can engage various cellular pathways to induce its activation, each employing a different mechanism of action. Forskolin is known for its ability to directly stimulate adenylate cyclase, leading to an increase in intracellular cyclic AMP (cAMP) levels. The elevation of cAMP can subsequently activate protein kinase A (PKA), which is capable of phosphorylating a multitude of proteins, including Olr772. This phosphorylation serves as a regulatory mechanism for Olr772, altering its activity state. Similarly, Isoproterenol, through its engagement with beta-adrenergic receptors, leads to the activation of adenylate cyclase and a subsequent rise in cAMP levels. This cascade also culminates in the activation of PKA, which then can target Olr772 for activation through phosphorylation.
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can directly phosphorylate Olr772, altering its activity state. Ionomycin, by increasing intracellular calcium concentration, can activate calcium-dependent protein kinases that are potential activators of Olr772 through phosphorylation. Inhibitors of protein phosphatases like Calyculin A and Okadaic Acid prevent the dephosphorylation of proteins, which could result in a sustained activation state of Olr772. Anisomycin, by activating stress-activated protein kinases such as JNK, can lead to the phosphorylation and consequent activation of Olr772. Epidermal Growth Factor (EGF) stimulates the MAPK/ERK pathway, which is involved in the phosphorylation of various proteins and could include Olr772 as a target for activation. Hydrogen Peroxide can lead to the oxidative modification of cysteine residues on proteins, which in Olr772's case, may result in its activation. Lithium Chloride's inhibition of GSK-3 and the subsequent activation of the Wnt signaling pathway may indirectly lead to the activation of Olr772. A23187 (Calcimycin) and Dibutyryl cyclic AMP (db-cAMP) both raise intracellular calcium levels or mimic cAMP respectively, activating kinases that can phosphorylate and activate Olr772. Each chemical, through its unique mechanism, ensures the activation of Olr772, integrating various signaling pathways within the cellular milieu.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol binds to and activates beta-adrenergic receptors, which stimulate adenylate cyclase to increase cAMP and activate PKA. Activated PKA can phosphorylate Olr772, leading to its activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA functions as a PKC activator; PKC can subsequently phosphorylate Olr772, leading to its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium concentrations, which can activate calcium-dependent protein kinases that may phosphorylate and activate Olr772. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatase 1 and 2A, which prevents dephosphorylation of proteins, potentially maintaining Olr772 in an activated state. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid similarly inhibits protein phosphatases 1 and 2A, leading to sustained phosphorylation and activation of Olr772. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases such as JNK which may phosphorylate and activate Olr772. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Hydrogen Peroxide can modify cysteine residues on proteins and may alter the conformation of Olr772, leading to its activation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3, which can activate the Wnt signaling pathway. This pathway's downstream effects can lead to the activation of Olr772. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, increasing intracellular calcium levels that activate kinases which may phosphorylate and activate Olr772. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cAMP analog that diffuses into cells and activates PKA, which could phosphorylate and activate Olr772. | ||||||